Hormone replacement therapy and the risk of breast cancer

This publication has 25 references indexed in Scilit:

• The Effects of Tibolone in Older Postmenopausal Women
  New England Journal of Medicine, 2008
• Effect of Tibolone on Breast Cancer Cell Proliferation in Postmenopausal ER+ Patients: Results from STEM Trial
  Clinical Cancer Research, 2007
• Preferential prescribing of tibolone and combined estrogen plus progestogen therapy in postmenopausal women
  Menopause, 2007
• LIFT study is discontinued
  BMJ, 2006
• Menopausal Hormone Therapy After Breast Cancer: The Stockholm Randomized Trial
  JNCI Journal of the National Cancer Institute, 2005
• Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy
  JAMA, 2004
• Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women’s Health Initiative Randomized Trial
  Obstetrical & Gynecological Survey, 2003
• Breast cancer and hormone-replacement therapy in the Million Women Study
  The Lancet, 2003
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
  The Lancet, 1997